1. Phytochemicals in Traditional Chinese Herbal Medicine: Cancer Prevention and Epigenetics Mechanisms
   Zhi-hui Zhou et al, 2017, Curr Pharmacol Rep CrossRef
2. MicroRNA-1290 promotes asiatic acid-induced apoptosis by decreasing BCL2 protein level in A549 non-small cell lung carcinoma cells
   KI BBEUM KIM et al, 2014 CrossRef
3. miR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis
   Juan Xie, 2014, WJG CrossRef
4. Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview
   Alice S. T. Wong et al, 2015, Nat. Prod. Rep. CrossRef
5. Preliminary study on fabrication, characterization and synergistic anti-lung cancer effects of self-assembled micelles of covalently conjugated celastrol–polyethylene glycol–ginsenoside Rh2
   Peng Li et al, 2017, Drug Delivery CrossRef
6. MicroRNA expression profiles associated with acquired gefitinib-resistance in human lung adenocarcinoma cells
   XIAOJUN GE et al, 2015 CrossRef
7. Biochemical basis of cancer chemoprevention and/or chemotherapy with ginsenosides (Review)
   JOON-SEOK CHOI et al, 2013 CrossRef
8. Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A
   Qiruo Gao et al, 2018, Cell Prolif CrossRef
9. Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down-regulation of microRNA-31
   Yan Chen et al, 2018, J. Cell. Biochem. CrossRef
10. Natural scaffolds in anticancer therapy and precision medicine
    Aloran Mazumder et al, 2018, Biotechnology Advances CrossRef
11. Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and prevention
    Bernhard Biersack, 2016, Non-coding RNA Research CrossRef
12. Transformation of ginsenoside Rh4 and its aglycone from the total saponins of stems and leaves of Panax ginseng by Aspergillus tubingensis
    Ying-Ying Wu et al, 2018, Phytochemistry Letters CrossRef
13. Relations between approved platinum drugs and non-coding RNAs in mesothelioma
    Bernhard Biersack, 2018, Non-coding RNA Research CrossRef
14. Combination of Ginsenoside H dripping pills and cyclophosphamide improve paraneoplastic syndrome and inhibit postoperative recurrence via the reversion of Th1/Th2 shift
    Fengfei Chen et al, 2018, Biomedicine & Pharmacotherapy CrossRef
15. Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma
    Bernhard Biersack, 2018, Non-coding RNA Research CrossRef
16. Black Ginseng and Its Saponins: Preparation, Phytochemistry and Pharmacological Effects
    Ahmed M. Metwaly et al, 2019, Molecules CrossRef
17. Betulin and its derivatives as novel compounds with different pharmacological effects
    Shayan Amiri et al, 2019, Biotechnology Advances CrossRef
18. Novel multicore niosomes based on double pH-sensitive mixed micelles for Ginsenoside Rh2 delivery
    Daquan Chen et al, 2014, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
19. Identification of Target Genes Involved in the Antiproliferative Effect of Enzyme-Modified Ginseng Extract in HepG2 Hepatocarcinoma Cell
    Sung-Il Jang et al, 2013, Evidence-Based Complementary and Alternative Medicine CrossRef
20. null
    Ehsan Ghaedi et al, 2019 CrossRef
21. Ginseng on Cancer: Potential Role in Modulating Inflammation-Mediated Angiogenesis
    Daisy Dai et al, 2017, Am. J. Chin. Med. CrossRef
22. 20(S)-Ginsenoside Rh2 displays efficacy against T-cell acute lymphoblastic leukemia through the PI3K/Akt/mTOR signal pathway
    Ting Xia et al, 2019, Journal of Ginseng Research CrossRef
23. null
    Jun-Rong Du et al, 2014 CrossRef
24. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma
    Weiwen Chen et al, 2015, Cell Biochem Biophys CrossRef
25. Neuroprotective therapeutics from botanicals and phytochemicals against Huntington's disease and related neurodegenerative disorders
    Abhijit Dey et al, 2015, Journal of Herbal Medicine CrossRef
26. Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals
    Yue Guo et al, 2015, Curr Pharmacol Rep CrossRef
27. Ginsenoside Rh2 differentially Mediates microRNA Expression to Prevent Chemoresistance of Breast Cancer
    Xu Wen et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
28. Induction of Forkhead Class box O3a and apoptosis by a standardized ginsenoside formulation, KG-135, is potentiated by autophagy blockade in A549 human lung cancer cells
    Chih-Jung Yao et al, 2017, Journal of Ginseng Research CrossRef
29. Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-α signaling pathway
    Jingjia Huang et al, 2016, Acta Biochim Biophys Sin CrossRef
30. How Ginsenosides Trigger Apoptosis in Human Lung Adenocarcinoma Cells
    Han Xiao et al, 2019, Am. J. Chin. Med. CrossRef
31. Chinese Herbal Medicine-Based Cancer Therapy: Novel Anticancer Agents Targeting MicroRNAs to Regulate Tumor Growth and Metastasis
    Fu Peng et al, 2019, Am. J. Chin. Med. CrossRef
32. Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia via mir-491
    Yingying Chen et al, 2019, ACAMC CrossRef
33. The component formula of Salvia miltiorrhiza and Panax ginseng induces apoptosis and inhibits cell invasion and migration through targeting PTEN in lung cancer cells
    Lei Bi et al, 2017, Oncotarget CrossRef
34. Anticancer property of ginsenoside Rh2 from ginseng
    Xun Li et al, 2020, European Journal of Medicinal Chemistry CrossRef
35. MicroRNA‑146a‑5p enhances ginsenoside Rh2‑induced anti‑proliferation and the apoptosis of the human liver cancer cell line HepG2
    Weiwen Chen et al, 2018, Oncol Lett CrossRef
36. Roles of plant‐derived bioactive compounds and related microRNAs in cancer therapy
    Heng Zou et al, 2020, Phytotherapy Research CrossRef
37. Increased antitumor efficacy of ginsenoside Rh2 via mixed micelles: in vivo and in vitro evaluation
    Xiaojing Xia et al, 2020, Drug Delivery CrossRef
38. Pharmacokinetics of Ginsenoside Rh2, the Major Anticancer Ingredient of Ginsenoside H Dripping Pills, in Healthy Subjects.
    Zhenlei Wang et al, 2021, Clin Pharmacol Drug Dev CrossRef
39. Ginsenoside Rg1 Induces Apoptotic Cell Death in Triple-Negative Breast Cancer Cell Lines and Prevents Carcinogen-Induced Breast Tumorigenesis in Sprague Dawley Rats
    Yan Chu et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
40. Regulation of microRNA-21 expression by natural products in cancer.
    Abolfazl Shakeri et al, 2021, Phytother Res CrossRef
41. CELF Family Proteins in Cancer: Highlights on the RNA-Binding Protein/Noncoding RNA Regulatory Axis
    Maryam Nasiri-Aghdam et al, 2021, IJMS CrossRef
42. The potential role of miR‐1290 in cancer progression, diagnosis, prognosis, and treatment: An oncomiR or onco‐suppressor microRNA?
    Mohammad Reza Kalhori et al, 2021, J Cell Biochem CrossRef
43. Network Pharmacology-Based Prediction and Verification of Ginsenoside Rh2-Induced Apoptosis of A549 Cells via the PI3K/Akt Pathway
    Chao Song et al, 2022, Front. Pharmacol. CrossRef
44. Saponins as cytotoxic agents: an update (2010–2021). Part II—Triterpene saponins
    Irma Podolak et al, 2022, Phytochem Rev CrossRef
45. Ginsenoside Rh2 Ameliorates Neuropathic Pain by inhibition of the miRNA21-TLR8-mitogen-activated protein kinase axis
    Yuan-Yuan Fu et al, 2022, Mol Pain CrossRef
46. Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation
    Sun Xiaodan et al, 2022, Biomedicine & Pharmacotherapy CrossRef
47. A systematic review of phytochemicals from Chinese herbal medicines for non-coding RNAs-mediated cancer prevention and treatment: From molecular mechanisms to potential clinical applications
    Wenjuan Zhai et al, 2022, Medicine in Novel Technology and Devices CrossRef
48. Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms
    Lu Ding et al, 2023, Biomedicine & Pharmacotherapy CrossRef
49. Potential of ginsenoside Rh2and its derivatives as anti-cancer agents
    Keke LI et al, 2022, Chinese Journal of Natural Medicines CrossRef
50. A New Frontier in Studying Dietary Phytochemicals in Cancer and in Health: Metabolic and Epigenetic Reprogramming
    Ahmad Shannar et al, 2022, Prev. Nutr. Food Sci. CrossRef
51. Ginsenoside Rh2 attenuates the progression of non‐small cell lung cancer by sponging miR ‐28‐5p/ STK4 axis and inactivating Wnt/β‐catenin signaling
    Jun Ma et al, 2023, Cancer Medicine CrossRef
52. Ginsenosides: a potential natural medicine to protect the lungs from lung cancer and inflammatory lung disease
    Lina Wang et al, 2023, Food Funct. CrossRef
53. Self-Assembled Micelles Based on Ginsenoside Rg5 for the Targeted Treatment of PTX-Resistant Tumors
    Feiyan Gao et al, 2024, Mol. Pharmaceutics CrossRef
54. Ginsenoside Rb1 Inhibits the Proliferation of Lung Cancer Cells by Inducing the Mitochondrial-mediated Apoptosis Pathway
    Lin Feng et al, 2024, ACAMC CrossRef